↓ Skip to main content

Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, March 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
103 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
Published in
Journal of Pharmaceutical Policy and Practice, March 2021
DOI 10.1186/s40545-021-00311-0
Pubmed ID
Authors

Virginia Ronco, Myriam Dilecce, Elena Lanati, Pier Luigi Canonico, Claudio Jommi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 103 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 18%
Student > Master 14 14%
Researcher 7 7%
Student > Bachelor 6 6%
Other 6 6%
Other 4 4%
Unknown 47 46%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 11 11%
Medicine and Dentistry 8 8%
Biochemistry, Genetics and Molecular Biology 7 7%
Nursing and Health Professions 6 6%
Social Sciences 5 5%
Other 16 16%
Unknown 50 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2022.
All research outputs
#6,949,499
of 22,788,370 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#165
of 405 outputs
Outputs of similar age
#156,169
of 423,801 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#8
of 22 outputs
Altmetric has tracked 22,788,370 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 405 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,801 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.